NPS Pharmaceuticals Inc

NPS Pharmaceuticals — Merger or Acquisition (March 2003)

9 slides from NPS Pharmaceuticals's merger presentation, Mar 27, 2003

  1. Slide 1: Science, Pipeline, Products: Creating a Biotechnology Leader

    Science, Pipeline, Products: Creating a Biotechnology Leader

  2. Slide 2: To Build a Sustainable Top-Tier Biotech Based On

    To Build a Sustainable Top-Tier Biotech Based On: • A deep, diversified and sustainable pipeline • A clearly defined pathway to profitability • A fully integrated infrastructure and stable financial position

  3. Slide 3: Platform

    Platform Technologies Preclinical *PEGylation J «SCA Projects *Single-Chain |] * PEG: Antibodies cytoxice) + Inhaled Leuprolide Phase! Phase I Commercialization Phase Ill & Manufacturing + PEG-INTRON * ABELCET * ADAGEN * ONCASPAR *DEPOCYT NPS mm ENZON

  4. Slide 4: Pipeline, Products & Technologies

    Pipeline, Products & Technologies

  5. Slide 5: ABELCET, ONCASPAR, DEPOCYT, ADAGEN

    • ABELCET ® • ONCASPAR ® • DEPOCYT ® • ADAGEN ®

  6. Slide 6: PREOS (Cinacalcet HCl)

    PREOS TM Cinacalcet HCI

  7. Slide 7: Operational Overview

    Operational Overview

  8. Slide 8: Locations

    Locations Manufacturing: Indianapolis, IN Research: /Toronto, Canada _ Manufacturing: Toronto, Canada Research: Piscataway, NJ Manufacturing: South Plainfield, NJ Headquarters: Research: Bridgewater, NU Salt Lake City, Utah

  9. Slide 9: Science, Pipeline, Products: Creating a Biotechnology Leader

    Science, Pipeline, Products: Creating a Biotechnology Leader

NPS Pharmaceuticals — Merger or Acquisition (March 2003) on 6ix